Assessment of PRO Label Claims Granted by the FDA as Compared to the EMA (2006-2010)

Marci Clark; A Gnanasakthy; Margaret Mordin; Emily Haydysch; Lynda Doward; Carla DeMuro-Mercon

RTI uses cookies to offer you the best experience online. By and clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Accept

Assessment of PRO Label Claims Granted by the FDA as Compared to the EMA (2006-2010)

DeMuro-Mercon, C., Doward, L., Haydysch, E., Mordin, M., Gnanasakthy, A., & Clark, M. (2013). Assessment of PRO Label Claims Granted by the FDA as Compared to the EMA (2006-2010). Value in Health, 16(8), 1150 - 5.

Copy citation

Recent Publications

Article

The evolution of minimally invasive tissue sampling in postmortem examination

Article

Accountability for SRHR in the context of the COVID-19 pandemic

Article

Validation of simple dichotomous self-report on prenatal alcohol and other drug use in women attending midwife obstetric units in the Cape Metropole, South Africa

Assessment of PRO Label Claims Granted by the FDA as Compared to the EMA (2006-2010)

Publications Info

Meet the Experts

Lynda Doward

Carla J. DeMuro-Mercon

Recent Publications

Article

The evolution of minimally invasive tissue sampling in postmortem examination

Article

Accountability for SRHR in the context of the COVID-19 pandemic

Article

Validation of simple dichotomous self-report on prenatal alcohol and other drug use in women attending midwife obstetric units in the Cape Metropole, South Africa

Article

Progress in the solvent depolymerization of lignin